TCANCER Trademark

Trademark Overview


On Thursday, April 24, 2025, a trademark application was filed for TCANCER with the United States Patent and Trademark Office. The USPTO has given the TCANCER trademark a serial number of 79437944. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, December 3, 2025. This trademark is owned by HS Diagnomics GmbH. The TCANCER trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Maintenance of databases of medical patient information; maintenance of databases of oncological information; maintenance of medical databases; maintenance of databases.

Computerised medical evaluation and diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines; computerised medical diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines.

Blood analysis services; development of databases of medical patient information; development of databases of oncological information; development of databases of sequenced t-cell receptors (tcrs); development of medical databases; development of databases; development of pharmaceutical preparations and medicines; laboratory services in the medical field; maintenance of databases; medical research in the field of immunology, oncology, infectiology and vaccines; performing analyses for medical research; performing chemical analyses; platform as a service; research and development of pharmaceutical preparations for treating malignant tumours; research of pharmaceuticals; research services in the field of medical analyses and diagnostics; scientific research and development in identification of tumour antigens; scientific research and development in the field of immunology, oncology, infectiology and vaccines; scientific research and development in the field of t-cell receptors (tcrs); sc...

Chemical products for medical diagnosis; diagnostic preparations for medical use, using t-cell receptors (tcrs); diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic reagents for medical or veterinary use in in vitro diagnosis; diagnostic substances for medical use; diagnostic test kits for cancer diagnosis; diagnostic test kits for individual medical diagnosis; diagnostic test kits for tumour identification; diagnostic test kits for use in oncology; diagnostic test reagents for veterinary use; indicators for medical diagnosis; medical diagnostic reagents; medical preparations; pharmaceutical drugs; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances; pharmaceutical preparations for diagnosis; pharmaceutical preparations for diagnostic purposes; pharmaceutical preparations for individual medical diagnosis; pharmaceutical preparations for medical purposes; pharmace...
tcancer

General Information


Serial Number79437944
Word MarkTCANCER
Filing DateThursday, April 24, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, December 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMaintenance of databases of medical patient information; maintenance of databases of oncological information; maintenance of medical databases; maintenance of databases.
Pseudo MarkT CANCER
Goods and ServicesComputerised medical evaluation and diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines; computerised medical diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines.
Goods and ServicesBlood analysis services; development of databases of medical patient information; development of databases of oncological information; development of databases of sequenced t-cell receptors (tcrs); development of medical databases; development of databases; development of pharmaceutical preparations and medicines; laboratory services in the medical field; maintenance of databases; medical research in the field of immunology, oncology, infectiology and vaccines; performing analyses for medical research; performing chemical analyses; platform as a service; research and development of pharmaceutical preparations for treating malignant tumours; research of pharmaceuticals; research services in the field of medical analyses and diagnostics; scientific research and development in identification of tumour antigens; scientific research and development in the field of immunology, oncology, infectiology and vaccines; scientific research and development in the field of t-cell receptors (tcrs); scientific research and development; software as a service; scientific research and development services for medical and pharmaceutical purposes in relation to the following fields: immunology, oncology, infectiology and vaccines; research and development services in connection with pharmaceutical and medical preparations, medicine and pharmaceuticals in relation to the following fields: immunology, oncology, infectiology and vaccines; computerised medical evaluation and diagnostic services in relation to the following fields: immunology, oncology, infectiology and vaccines.
Goods and ServicesChemical products for medical diagnosis; diagnostic preparations for medical use, using t-cell receptors (tcrs); diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic reagents for medical or veterinary use in in vitro diagnosis; diagnostic substances for medical use; diagnostic test kits for cancer diagnosis; diagnostic test kits for individual medical diagnosis; diagnostic test kits for tumour identification; diagnostic test kits for use in oncology; diagnostic test reagents for veterinary use; indicators for medical diagnosis; medical diagnostic reagents; medical preparations; pharmaceutical drugs; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances; pharmaceutical preparations for diagnosis; pharmaceutical preparations for diagnostic purposes; pharmaceutical preparations for individual medical diagnosis; pharmaceutical preparations for medical purposes; pharmaceutical preparations for medical test kits for cancer diagnosis; pharmaceutical preparations for medical test kits for individual medical diagnosis; pharmaceutical preparations for medical test kits for use in oncology; pharmaceutical preparations for medical test kits; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the diagnosis of diseases; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations; pharmaceutical products, medical and veterinary preparations; pharmaceuticals for the treatment of cancer; pharmaceuticals; preparations for medical diagnosis; reactants for medical diagnosis; reagents and preparations for use in diagnostic tests for medical purposes; reagents for diagnostic tests for medical use; tests and test kits for profiling, in particular genomic and proteomic profiling, for use in the selection of therapeutics; tests and test kits for the diagnosis of diseases; tests, test kits, preparations and reagents using t-cell receptors (tcrs) for oncological purposes; tests, test kits, preparations and reagents using t-cell receptor (tcr) clusters for oncological purposes; tumour suppressing agents; immunomodulators; immunostimulants; immunotherapeutic agents; pharmaceutical products for the treatment of autoimmune diseases and autoimmune disorders, pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of immune system disorders.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHS Diagnomics GmbH
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressDE

Trademark Events


Event DateEvent Description
Thursday, November 27, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, December 3, 2025ASSIGNED TO EXAMINER